Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Outbreak of Pneumococcal Pneumonia among Military Recruits.

Banerjee A, Kalghatgi AT, Saiprasad GS, Nagendra A, Panda BN, Dham SK, Mahen A, Menon KD, Khan MA.

Med J Armed Forces India. 2005 Jan;61(1):16-21. doi: 10.1016/S0377-1237(05)80111-X. Epub 2011 Jul 21.

2.

Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections Program.

Moore MR, Whitney CG.

Emerg Infect Dis. 2015 Sep;21(9):1551-6. doi: 10.3201/eid2109.150395.

3.

Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumonia.

Barakat LA, Juthani-Mehta M, Allore H, Trentalange M, Tate J, Rimland D, Pisani M, Akgün KM, Goetz MB, Butt AA, Rodriguez-Barradas M, Duggal M, Crothers K, Justice AC, Quagliarello VJ.

HIV Med. 2015 Aug;16(7):421-30. doi: 10.1111/hiv.12244. Epub 2015 May 11.

4.

Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Mercante JW, Winchell JM.

Clin Microbiol Rev. 2015 Jan;28(1):95-133. doi: 10.1128/CMR.00029-14. Review.

5.

Aerosolization of respirable droplets from a domestic spa pool and the use of MS-2 coliphage and Pseudomonas aeruginosa as markers for Legionella pneumophila.

Moore G, Hewitt M, Stevenson D, Walker JT, Bennett AM.

Appl Environ Microbiol. 2015 Jan;81(2):555-61. doi: 10.1128/AEM.02912-14. Epub 2014 Nov 7.

6.

Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus.

Ivanov S, Paget C, Trottein F.

PLoS Pathog. 2014 Oct 9;10(10):e1004300. doi: 10.1371/journal.ppat.1004300. eCollection 2014 Oct. Review.

7.

Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures?

Campbell SG, McIvor RA, Joanis V, Urquhart DG.

World J Emerg Med. 2011;2(4):272-8. doi: 10.5847/wjem.j.1920-8642.2011.04.005.

8.

Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.

Majhi A, Kundu K, Adhikary R, Banerjee M, Mahanti S, Basu A, Bishayi B.

J Inflamm (Lond). 2014 Feb 24;11(1):5. doi: 10.1186/1476-9255-11-5.

9.

Macrolide use in the treatment of critically ill patients with pneumonia: Incidence, correlates, timing and outcomes.

Sligl WI, Hoang H, Eurich DT, Malhotra A, Marrie TJ, Majumdar SR.

Can J Infect Dis Med Microbiol. 2013 Winter;24(4):e107-12.

10.

Etiology and Anti-microbial Sensitivity of Organisms Causing Community Acquired Pneumonia: A Single Hospital Study.

Menon RU, George AP, Menon UK.

J Family Med Prim Care. 2013 Jul;2(3):244-9. doi: 10.4103/2249-4863.120728.

11.

Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumonia.

Georges H, Journaux C, Devos P, Alfandari S, Delannoy PY, Meybeck A, Chiche A, Boussekey N, Leroy O.

BMC Infect Dis. 2013 Apr 30;13:196. doi: 10.1186/1471-2334-13-196.

12.

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL; AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, Boulware DR, Butler JC, Carratalà J, Chang FY, Charles PG, Diaz AA, Domínguez J, Ehara N, Endeman H, Falcó V, Falguera M, Fukushima K, Garcia-Vidal C, Genne D, Guchev IA, Gutierrez F, Hernes SS, Hoepelman AI, Hohenthal U, Johansson N, Kolek V, Kozlov RS, Lauderdale TL, Mareković I, Masiá M, Matta MA, Miró Ò, Murdoch DR, Nuermberger E, Paolini R, Perelló R, Snijders D, Plečko V, Sordé R, Strålin K, van der Eerden MM, Vila-Corcoles A, Watt JP.

PLoS One. 2013;8(4):e60273. doi: 10.1371/journal.pone.0060273. Epub 2013 Apr 2. Review.

13.

Diagnostic usefulness of ribosomal protein l7/l12 for pneumococcal pneumonia in a mouse model.

Sawa T, Kimura S, Honda NH, Fujita K, Yoshizawa S, Harada Y, Sugiyama Y, Matsuyama K, Sohka T, Saji T, Yamaguchi K, Tateda K.

J Clin Microbiol. 2013 Jan;51(1):70-6. doi: 10.1128/JCM.01871-12. Epub 2012 Oct 24.

14.

Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?

Asai N, Motojima S, Ohkuni Y, Matsunuma R, Nakasima K, Iwasaki T, Nakashita T, Otsuka Y, Kaneko N.

Multidiscip Respir Med. 2012 Jun 11;7(1):2. doi: 10.1186/2049-6958-7-2.

15.
16.

The new fluoroquinolones: A critical review.

Zhanel GG, Walkty A, Vercaigne L, Karlowsky JA, Embil J, Gin AS, Hoban DJ.

Can J Infect Dis. 1999 May;10(3):207-38.

17.
18.

Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?

Endimiani A, Hujer KM, Hujer AM, Kurz S, Jacobs MR, Perlin DS, Bonomo RA.

Clin Infect Dis. 2011 May;52 Suppl 4:S373-83. doi: 10.1093/cid/cir054. Review.

19.

Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.

Still JG, Schranz J, Degenhardt TP, Scott D, Fernandes P, Gutierrez MJ, Clark K.

Antimicrob Agents Chemother. 2011 May;55(5):1997-2003. doi: 10.1128/AAC.01429-10. Epub 2011 Jan 31.

20.

Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study.

Jiang LJ, Or YS.

Antimicrob Agents Chemother. 2009 Aug;53(8):3218-25. doi: 10.1128/AAC.00022-09. Epub 2009 May 18.

Supplemental Content

Support Center